Intratumoural expression of deoxycytidylate deaminase or ribonuceotide reductase subunit M1 expression are not related to survival in patients with resected pancreatic cancer given adjuvant chemotherapy
Sign Up to like & getrecommendations! Published in 2018 at "British Journal of Cancer"
DOI: 10.1038/s41416-018-0005-1
Abstract: BackgroundDeoxycytidylate deaminase (DCTD) and ribonucleotide reductase subunit M1 (RRM1) are potential prognostic and predictive biomarkers for pyrimidine-based chemotherapy in pancreatic adenocarcinoma.MethodsImmunohistochemical staining of DCTD and RRM1 was performed on tissue microarrays representing tumour samples from… read more here.
Keywords: chemotherapy; reductase subunit; pancreatic cancer; expression ... See more keywords